Cero Therapeutics Holdings (CERO) Share-based Compensation (2023 - 2026)
Cero Therapeutics Holdings (CERO) reported Share-based Compensation of $1.12 million for Q2 2026, up 512.1% from $183,328 a year earlier but down 30.6% from the prior quarter.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cero Therapeutics Holdings' Share-based Compensation came in at $3.35 million; for FY2025, it came in at $1.1 million, up 18.5% from FY2024.
- By year, Share-based Compensation came in at $924,668 in FY2024 (+854.3%) and $96,896 in FY2023.
- Five-year quarterly Share-based Compensation spans a low of -$975,103 in Q4 2024 and a high of $1.62 million in Q1 2026.
- Year over year, Share-based Compensation gained in three of the last five quarters, with growth averaging 211.3%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.62 million (Q1 2026), $259,666 (Q4 2025) and $348,116 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Cero Therapeutics Holdings | 638,128.24 | -4.84 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 259,666.00 |
| Sep 30, 2025 | 348,116.00 |
| Jun 30, 2025 | 707,300.00 |
| Mar 31, 2025 | 304,946.00 |
| Dec 31, 2024 | -975,103.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 16,896.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 28,144.00 |
API Access
Cero Therapeutics Holdings Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();